Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reverse transcriptase (RT) is an enzyme that catalyzes the synthesis of complementary DNA (cDNA) from an RNA template. This activity is essential for the replication of retroviruses such as HIV and hepatitis B, as well as for the proliferation of retrotransposons within host genomes. RTs are also found in eukaryotic cells, where they play a role in telomere maintenance via telomerase. Inhibitors targeting reverse transcriptases form key components of antiretroviral therapies against diseases like HIV/AIDS.
Inhibition of reverse transcriptase activity, blocking cDNA synthesis and viral replication.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reverse Transcriptase (RT).